logo
Closing the funding gap — how SA can respond to US aid cuts

Closing the funding gap — how SA can respond to US aid cuts

Daily Maverick11-07-2025
South Africa still lacks an action plan after the withdrawal of US aid for HIV and related health services. But when funds do arrive, how will they be managed? The answer may lie in the District Health Programme Grant.
The government's extended silence on how it plans to solve the funding crisis created by the withdrawal of US aid has thrown much of the health sector in South Africa into despair.
It has been five months since the withdrawal of the aid amounting to about R7-billion per year. It covered the salaries for 15,000 health workers, of whom 8,000 are community health workers, 2,000 are nurses, and 300 are doctors working in 27 of South Africa's high HIV priority districts. As a result, volumes of high-risk populations have lost access to care, while overstretched healthcare workers are facing increased pressure amid ongoing staff shortages.
Recently, the Global HIV Treatment Coalition and civil society organisations wrote a strongly worded letter to the government demanding action on a fully costed emergency plan. They accused the state of not taking concerted action.
They are not wrong: The government has still not made a clear plan available to the public, although there is consensus on the urgent need to strengthen the emergency response.
Plans have been developed internally in the National Department of Health, and a national technical support unit has been established in the office of the health department's director-general to support the integration of services. It is understood that several provinces are being supported to develop provincial transition plans that can be translated into concrete action.
But ongoing discussions with the National Treasury have made little meaningful progress in closing the funding gap. The Treasury has indicated that any new funding will either be part of the adjustment budget or as an emergency allocation. At this stage, it is still unclear how much money, if any, will be allocated.
There is another challenge that is yet to be considered. When the funding does arrive, there will need to be consensus on how the money is coordinated, incubated and managed.
Here, the answer may already be in our back pockets in the form of the District Health Programme Grant. The grant is a mechanism for funding South Africa's public health efforts, particularly relating to HIV, TB and other communicable diseases. As an existing instrument, this grant programme could help address issues linked to the funding gap and lay the foundation for the sustainable integration of activities previously funded by the US President's Emergency Plan for Aids Relief (Pepfar).
Why the District Health Programme Grant could work
The District Health Programme Grant presents an ideal mechanism that can be used to strengthen governance and ensure that the funding, plans and activities, down to a district level, align with national campaigns and priorities.
The grant would need to be amended to ensure that there is improved management of the conditionalities so that the funds invested meet their purpose. Conditional grants are funds allocated to provinces with the primary purpose of ensuring that national priorities are implemented consistently across the country. They facilitate targeted service delivery, equity, accountability and performance monitoring.
The District Health Programme Grant, which has a budget of about R25-billion, already has a large HIV component, so additional funding for the HIV and TB services that are needed could easily be allocated to this grant.
And if the health department amended the grant mechanism to allow for the contracting in of service providers, such as the Pepfar implementing agents, which are mostly South African NGOs previously funded by the US government, the country would be able to use the capacity built up over time in these organisations to strengthen the delivery of HIV and TB services.
The concern, however, is accountability.
In the current set-up of the grant, provinces can act more autonomously, and the grant's conditionalities are poorly managed. For the system to be more effective, there needs to be a greater emphasis on cooperative engagement, where two-way reporting between the national and provincial levels can take place.
Amending the grant to include stronger accountability mechanisms would help the health department to better coordinate and manage it.
The clock is ticking
The funding gap comes at a time when the health department has launched two ambitious campaigns to tackle HIV and TB. The Close the Gap campaign aims to enrol a record number — an additional 1.1 million — of people living with HIV on life-saving antiretroviral medicine this year.
Along with teenage girls and young women, the initiative prioritises an estimated 600,000 men who know their status but are not on treatment. This campaign aligns with the country's strategy to end TB by 2030. This year, the health department also hopes to accelerate TB case-finding by scaling up testing to five million TB tests to reduce the high rate of infections and deaths.
The linkages between the campaigns make sense. TB is the leading comorbidity for people living with HIV. HIV is also the leading contributor to TB mortality, accounting for an estimated 55% of TB deaths, according to the World Health Organization's data on TB in South Africa. The campaigns are evidence-informed and well considered.
However, the ambition is not matched by budgets that can support and ultimately enable its success. In addition to the R7-billion Pepfar funding gap, there is a funding gap of at least R600-million in TB to sufficiently fund the required five million tests needed for the campaign. Funding pressures at the provincial level are also constraining the scaling up of the capacity required to administer the tests.
A recent analysis by the South African National Aids Council situation room, which every month evaluates the HIV response as part of the Close the Gap campaign, suggests that while there are increases in the number of people being initiated on HIV treatment, the pace is not fast enough to mitigate the losses SA experiences in retaining patients in care. This has resulted in negative growth in many high-prevalence districts.
Similarly, in the first TB provincial managers' programme meeting coordinated by the national TB programme, reports of poor performance against the testing targets underpinned the underlying frustrations many are experiencing.
South Africa has made incredible progress in expanding access to healthcare in the last 30 years. These include significant declines in maternal mortality, decreases in the under-5 mortality rates, and significant declines in the incidence of TB. Much of this success, particularly in the last decade, is the result of the mass rollout of lifesaving antiretroviral treatment to about six million of the estimated eight million people in SA living with HIV.
The abrupt withdrawal of US aid has put at least some of this progress under threat.
As we look to the mid-year adjustments budget, we don't just need new money to plug the gap; we also need a sensible framework for spending that money. Channelling the funds through a tweaked District Health Programme Grant is a financial solution that will both provide some quick relief and mitigate the impact that the funding gap will have on universal health coverage more broadly in the long run.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Measles outbreak in Gauteng: 181 cases confirmed, public urged to vaccinate
Measles outbreak in Gauteng: 181 cases confirmed, public urged to vaccinate

The Citizen

time11 hours ago

  • The Citizen

Measles outbreak in Gauteng: 181 cases confirmed, public urged to vaccinate

The Gauteng Department of Health has intensified its public health response following further measles cases across the province. Between January 1 and June 13, 181 laboratory-confirmed measles cases were reported, primarily in Johannesburg, Tshwane, and Ekurhuleni. In the latest reporting period, Gauteng recorded 15 new measles cases. Local nurse Nhlanhla Mofokeng explained what measles is and how to curb its spread. She defined measles as a highly contagious viral infection that mainly affects children but can infect anyone who is unvaccinated. 'It spreads through droplets in the air when an infected person coughs, sneezes, or talks. Measles symptoms appear about seven to 14 days after exposure,' she said. Signs and symptoms: • High fever; • Dry cough; • Runny nose; • Red, watery eyes; • Tiny white spots inside the mouth (Koplik spots); • A blotchy red rash that usually starts on the face and spreads downward. 'A person is contagious four days before and four days after the rash appears. Many people assume measles is just a rash and fever, but it can lead to severe complications,' she added. She mentioned these complications: • Pneumonia; • Diarrhoea and dehydration; • Ear infections (which might lead to hearing loss); • Brain swelling (encephalitis); • Death, especially in malnourished children or those with weakened immune systems. 'Children under five years, unvaccinated people of any age, people with weakened immune systems (HIV+ individuals) and pregnant women are at risk of contracting measles. 'Prevention is always better than cure. The measles vaccine is safe and free at public clinics across SA. It is given as part of the Measles, Mumps, and Rubella vaccine (MMR) at six months (extra dose during outbreaks), 12 months and 18 months,' she mentioned. Mofokeng said vaccination is the best protection because if enough people are vaccinated, the virus cannot spread; this is called herd immunity. She added that during the outbreak, people must ensure children are vaccinated by checking their Road-to-Health card. The nurse advised adults unsure of their vaccination status to visit a clinic for advice. 'If your child shows symptoms, keep them at home and visit a health facility immediately. Inform your school or crèche if a child was diagnosed. They may need to take steps to prevent further spread,' said Mofokeng. What to do if you suspect measles? • Step one: Seek medical care immediately; early detection can prevent serious illness. • Step two: Isolate the patient to avoid spreading the virus to others. • Step three: Follow the instructions from your clinic or doctor. ALSO READ: SASSA announces August payment dates for all social grants ALSO READ: Two arrested in Kwa-Thema for house robbery and possession of unlicensed firearms

Mobile clinics bring life-saving cancer screening to rural communities
Mobile clinics bring life-saving cancer screening to rural communities

IOL News

time14 hours ago

  • IOL News

Mobile clinics bring life-saving cancer screening to rural communities

A groundbreaking partnership is bringing vital cancer screenings to South Africa's rural communities. Image: Supplied In South Africa, the challenge of healthcare access is a story of two halves. While urban centres have a network of hospitals and clinics, many rural communities face significant hurdles, often leading to late diagnoses for serious illnesses. This is especially true for cancer, where early detection can make all the difference. Non-communicable diseases (NCDs) are responsible for a staggering 65% of all natural causes of death in our country, a burden that the National Department of Health is working hard to reduce. It is in this context that a partnership is making a real difference: a collaboration between Rio Tinto, PinkDrive, and the National Department of Health to bring essential health screening directly to those who need it most. Starting in late July and running through August 2025, this initiative will see mobile healthcare screening clinics travelling through KwaZulu-Natal, the Eastern Cape, and the Northern Cape. This comes after a successful outreach in 2024, which laid the groundwork for this expanded mission. Werner Duvenhage, Managing Director of RTIT Africa Operations & RBM, shared his pride in the project, stating, 'We are proud to once again collaborate with PinkDrive to bring these services closer to those who need them most. Through this collaboration we can extend our reach and make a meaningful impact even in areas where we are not physically present. It is an extension of our core values.' The numbers from last year's outreach are impressive, with 7,695 people screened in just two weeks. This year, the goal is even more ambitious: to screen over 12,000 individuals and provide health education to many more. Noelene Kotschan, CEO and Founder of PinkDrive, highlighted the critical need for this type of service, explaining, 'Far too many South Africans are diagnosed late because they simply don't have access to screening facilities. Our model of mobile healthcare has proven both innovative and effective in bridging this gap.' PinkDrive's model is about bringing the healthcare facility to the community, using a fleet of mobile units to provide services that would otherwise be out of reach. The services offered are comprehensive and all provided at no cost. The mobile clinics will be staffed by a team of qualified doctors, nurses, radiographers, and health educators, offering everything from mammograms and pap smears to Prostate-Specific Antigen (PSA) tests, clinical breast examinations, and skin and lung cancer screenings. General health check-ups will also be available, with referrals to public health facilities arranged for anyone who needs further care. This initiative is a vital part of South Africa's national health goals, which focus on reducing the burden of NCDs through early detection, prevention, and improved access to care. The funding for this impactful project comes from the Rio Tinto Social Investment Fund, which is dedicated to creating lasting socio-economic benefits in the communities where the company operates. This collaboration is a powerful example of how public-private partnerships can directly improve health outcomes and bring essential services to the doorsteps of those who need them most, making a tangible difference in the lives of thousands of South Africans. IOL Lifestyle

Rethinking HIV treatment with tailored solutions for improved patient engagement and outcomes
Rethinking HIV treatment with tailored solutions for improved patient engagement and outcomes

Daily Maverick

timea day ago

  • Daily Maverick

Rethinking HIV treatment with tailored solutions for improved patient engagement and outcomes

The health department has R622-million extra to prop up South Africa's HIV treatment programme in the wake of foreign aid cuts. But it's only about a fifth of the total gap. We look at how data can help drive decisions to make the most of this lifebuoy. Just over two weeks ago, Health Minister Aaron Motsoaledi announced that the Treasury had given R622-million of emergency funding to his department to prop up South Africa's HIV treatment programme, with about R590-million for provinces' HIV budgets and R32-million for the chronic medicine distribution system, which allows people to fetch their antiretroviral treatment from pick-up points other than clinics, closer to their homes. This extra budget is just over a fifth of the roughly R2.8-billion funding gap that the health department says the country needed after US President Donald Trump's administration pulled the plug on financial support for HIV in February. (The Pepfar/Aids relief budget for this financial year was just under R8-billion, but the health department calculated that it could fill the void with R2.8-billion if it trimmed extras and ruled out duplicate positions.) So, how to get the best bang for these limited bucks — especially with the health department wanting to get 1.1-million people with HIV on treatment before the end of the year and so reach the United Nations targets for ending Aids as a public health threat by 2030? By getting really serious about giving people more than one way of getting their repeat prescriptions for antiretroviral (ARV) medicine (so-called differentiated service delivery), said Kate Rees, the co-chairperson of the 12th South African Aids Conference to be held later this year, from Kigali last week, where she attended the 13th IAS Conference on HIV Science. At another Kigali session, Lynne Wilkinson, a public health expert working with the health department on public health approaches to help people stay on treatment, said: 'People who interrupt their antiretroviral treatment are increasingly common, but so are people who re-engage, or in other words start their treatment again after having stopped for a short period.' A big part of South Africa's problem in getting 95% of people who know they have HIV on ARVs (the second target of the UN's 95-95-95 set of cascading goals) is that people — sometimes repeatedly — stop and restart treatment. For the UN goals to be reached, South Africa needs to have 95% of people diagnosed with HIV on treatment. Right now, the health department says, we stand at 79%. But the way many health facilities are run makes the system too rigid to accommodate real life stop-and-start behaviour, says Rees. This not only means that extra time and money are spent every time someone seemingly drops out of line and then comes back in, but also makes people unwilling to get back on board because the process is so inconvenient and unwelcoming. Rees and Wilkinson were the co-authors of a study published in the Journal of the International Aids Society in 2024, whose results helped the health department update the steps health workers should follow when someone has missed an appointment for picking up their medicine or getting a health check-up — and could possibly have stopped treatment. 'We often have excellent guidelines in place, built on solid scientific evidence,' says Rees, 'but they're not necessarily implemented well on the ground.' To make sure we track the second 95 of the UN goals accurately, we need a health system that acknowledges people will come late to collect their treatment and sometimes miss appointments. This doesn't necessarily mean they've stopped their treatment; rather that how they take and collect their treatment changes over time. 'The standard ways in which the public health system works mostly doesn't provide the type of support these patients need, as the resources required to provide such support is not available,' says Yogan Pillay, the health department's former deputy director-general for HIV and now the head of HIV delivery at the Gates Foundation. 'But with AI-supported digital health solutions and the high penetration of mobile phones, such support now can — and should — be provided at low cost and without the need to hire additional human resources.' We dived into the numbers to see what the study showed — and what they can teach us about making the system for HIV treatment more flexible. Does late equal stopped? Not necessarily. Data from three health facilities in Johannesburg that the researchers tracked showed that of the 2,342 people who came back to care after missing a clinic appointment for collection medication or a health check, 72% — almost three-quarters — showed up within 28 days of the planned date. In fact, most (65%) weren't more than two weeks late. Of those who showed up at their clinic more than four weeks after they were due, 13% made it within 90 days (12 weeks). Only one in 14 people in the study came back later than this, a period by which the health department would have recorded them as having fallen out of care. (Some incomplete records meant the researchers could not work out by how much 8% of the sample had missed their appointment date.) The data for the study was collected in the second half of 2022, and at the time national guidelines said that a medicine parcel not collected within two weeks of the scheduled appointment had to be sent back to the depot. 'But it's important to distinguish between showing up late and interrupting treatment,' notes Rees. Just because someone was late for their appointment doesn't necessarily mean they stopped taking their medication. Many people in the study said they either still had pills on hand or managed to get some, despite not showing up for their scheduled collection. Pepfar definitions say that a window of up to 28 days (that is, four weeks) can be tolerated for late ARV pick-ups. Pepfar is the US HIV programme that funds projects in countries like South Africa, but most of them were cut in February. Research has also shown that for many people who have been on treatment for a long time already, viral loads (how much HIV they have in their blood) start to pass 1,000 copies/mL — the point at which someone could start being infectious again — about 28 days after treatment has truly stopped. Sending back a parcel of uncollected medicine after just two weeks — as was the case at the time of the study — would therefore add an unnecessary administration load and cost into the system. (Current health department guidelines, updated since the study and in part because of the results, say that a medicine pick-up point can hold on to someone's medicine for four weeks after their scheduled appointment.) Does late equal unwell? Not always. In fact, seven out of 10 people who collected their next batch of medication four weeks or more late had no worrying signs, such as possible symptoms of tuberculosis, high blood pressure, weight loss or a low CD4 cell count, when checked by a health worker. (A low CD4 count means that someone's immune system has become weaker, which is usually a sign of the virus replicating in their body.) Moreover, given the large number of people without worrying health signs in the group for whom data was available, it's possible that many of those in the group with incomplete data were well too. When the researchers looked at the patients' last viral load results on file (some more than 12 months ago at the time of returning to the clinic), 71% had fewer than 1,000 copies/mL in their blood. A viral count of fewer than 1,000 copies/mL tells a health worker that the medicine is keeping most of the virus from replicating. It is usually a sign of someone being diligent about taking their pills and managing their condition well. Yet clinic staff often assume that people who collect their medicine late are not good at taking their pills regularly, and so they get routed to extra counselling about staying on the programme. 'Most people don't need more adherence counselling; they need more convenience,' says Rees. Offering services that aren't necessary because of an inflexible process wastes resources, she says — something a system under pressure can ill afford. Rees says: 'With funding in crisis, we really have to prioritise [where money is spent].' Does late equal indifferent? Rarely. Close to three-quarters of people who turned up four weeks or more after their scheduled medicine collection date said they had missed their appointment because of travelling, work commitments or family obligations. Only about a quarter of the sample missed their appointment because they forgot, misplaced their clinic card or for some other reason that would suggest they weren't managing their condition well. Part of making cost-effective decisions about how to use budgets best is to offer 'differentiated care', meaning that not every patient coming back after a missed appointment is treated the same way, says Rees. Health workers should look at by how much the appointment date was missed, as well as a patient's health status to decide what service they need, she says. Giving people who've been managing their condition well enough medicine to last them six months at a time can go a long way, Wilkinson told Bhekisisa's Health Beat team in July. 'Getting 180 pills in one go reduces the number of clinic visits [only twice a year], which eases the workload on staff. But it also helps patients to stay on their treatment by cutting down on their transport costs and time off work,' Wilkinson said. Zambia, Malawi, Lesotho and Namibia have all rolled out six-month dispensing — and have already reached the UN's target of having 95% of people on medicine at a virally suppressed level. According to the health department, South Africa will start rolling out six-month dispensing in August. 'But not everyone wants this,' said Wilkinson, pointing out that experiences from other countries showed that 50 to 60% of people choose six-monthly pick-ups. It speaks to tailoring service delivery to patients' needs, says Rees, rather than enforcing a one-size-fits-all system when more than one size is needed. Says Rees: 'Facing funding constraints, we really need tailored service delivery to keep the [HIV treatment] programme where it is.' DM

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store